CORC

在结果中检索

CORC

浏览/检索结果: 共8条，第1-8条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Yang, Zi-yan;  Huang, Jia-huan;  Chen, Bo;  Xu, Chun-wei;  Lei, Lei
收藏  |  浏览/下载：26/0  |  提交时间：2020/11/30
Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort. 期刊论文
The International journal of biological markers, 2019
作者:  Chuanxu Luo;  Xiaorong Zhong;  Zhu Wang;  Yu Wang;  Yanping Wang
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/17
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer 期刊论文
2019, 卷号: 118, 页码: 169-177
作者:  Huober, Jens;  Holmes, Eileen;  Baselga, Jose;  de Azambuja, Evandro;  Untch, Michael
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Predictors of breast cancer cell types and their prognostic power in breast cancer patients 期刊论文
BMC GENOMICS, 2018, 卷号: 19
作者:  Wang, Fan;  Dohogne, Zachariah;  Yang, Jin;  Liu, Yu;  Soibam, Benjamin
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26
Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis 期刊论文
BREAST CANCER, 2016, 卷号: 23, 期号: 5
作者:  Zhang, Qian;  Chen, Jian;  Yu, Xiaoli;  Cai, Gang;  Yang, Zhaozhi
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
HER2 amplification level is not a prognostic factor for HER2-positive breast cancer with trastuzumab-based adjuvant treatment: a systematic review and meta-analysis 期刊论文
2016, 卷号: 7, 期号: 39, 页码: 63571-63582
作者:  Xu, Qian-Qian;  Pan, Bo;  Wang, Chang-Jun;  Zhou, Yi-Dong;  Mao, Feng
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2013, 卷号: Vol.142 No.3, 页码: 549-558
作者:  Chen, Xiaosong;  Ye, Guolin;  Zhang, Chenfang;  Li, Xinzheng;  Chen, Yiding
收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2013, 卷号: 142, 页码: 549-558
作者:  Chen, Xiaosong[1];  Ye, Guolin[2];  Zhang, Chenfang[3];  Li, Xinzheng[4];  Chen, Yiding[5]
收藏  |  浏览/下载：7/0  |  提交时间：2019/04/25

©版权所有 ©2017 CSpace - Powered by CSpace